Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (002675.SZ)
CNY 12.54
(-0.32%)
CNY 12.54
(-0.32%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 276.94 Million | 996.53 Million | 943.58 Million | 572.57 Million | 696.37 Million | 493.06 Million |
| Net Income | 254.21 Million | 352.81 Million | 260.84 Million | 517.47 Million | 293.64 Million | 388.79 Million |
| Depreciation & Amortization | 147.24 Million | 125.09 Million | 114.93 Million | 102.74 Million | 96.05 Million | 80.47 Million |
| Deferred income taxes | -24.75 Million | -3.33 Million | -5.91 Million | 242.87 Thousand | -4.24 Million | -13.08 Million |
| Stock-based compensation | 1.57 Million | - | - | - | - | - |
| Change in working capital | -308 Million | 191.25 Million | 311.16 Million | -82.39 Million | 32.55 Million | -99.14 Million |
| Other non-cash items | 47.7 Million | 327.36 Million | 256.63 Million | 34.76 Million | 274.13 Million | 122.94 Million |
| Investing Cash Flow | -602.8 Million | -452.74 Million | -739.24 Million | -530.71 Million | -209.57 Million | 72.8 Million |
| Investments in PPE | -511.94 Million | -389.61 Million | -530.15 Million | -262.18 Million | -250.07 Million | -121.05 Million |
| Acquisitions | -202.18 Million | 33.02 Thousand | 286.66 Thousand | -99.11 Million | -103.7 Million | 0.12 |
| Investment purchases | -290.77 Million | -560.7 Million | -1.39 Billion | -2.08 Billion | -1.15 Billion | -1.24 Billion |
| Sales/Maturities of investments | 430.73 Million | 495.88 Million | 1.18 Billion | 1.9 Billion | 1.17 Billion | 1.34 Billion |
| Other Investing Activities | -29.71 Million | 1.65 Million | 321.02 | 13.61 Million | 116.91 Million | 95.63 Million |
| Financing Cash Flow | -675.86 Thousand | -359.12 Million | -188.68 Million | -141.48 Million | -552.89 Million | 4.21 Million |
| Debt repayment | -105.16 Million | -906.41 Million | -521.18 Million | -1.63 Billion | -1.06 Billion | -710.84 Million |
| Dividends payments | -123.68 Million | -120.33 Million | -200.55 Million | -200.55 Million | -38.5 Million | -132.82 Million |
| Common Stock Repurchased | - | - | - | - | 3.7 Million | - |
| Common Stock Issuance | - | - | - | - | -3.7 Million | - |
| Other Financing Activities | 152.48 Million | 798.53 Million | 634.97 Million | 1.83 Billion | 756.11 Million | 847.88 Million |
| Accounts receivables | 174.74 Million | -23.62 Million | 129.88 Million | -20.06 Million | -122.75 Million | -197.71 Million |
| Accounts payables | -524.11 Million | 330.57 Million | 176.68 Million | 32.14 Million | 440.11 Million | 62.47 Million |
| Inventory | 66.11 Million | -112.35 Million | 10.5 Million | -94.72 Million | -280.56 Million | 49.17 Million |
| Other working capital | 3.66 Million | -3.33 Million | -5.91 Million | 242.87 Thousand | -4.24 Million | -148.32 Million |
| Cash at beginning of period | 926.85 Million | 735.92 Million | 713.52 Million | 816.47 Million | 888.08 Million | 313.74 Million |
| Cash at end of period | 607.73 Million | 926.85 Million | 735.92 Million | 713.52 Million | 816.47 Million | 888.08 Million |
| Capital Expenditure | -511.94 Million | -389.61 Million | -530.15 Million | -262.18 Million | -250.07 Million | -121.05 Million |
| Effect of forex changes on cash | 7.41 Million | 6.26 Million | 6.74 Million | -3.31 Million | -5.52 Million | 4.25 Million |
| Net cash flow / Change in cash | -319.11 Million | 190.92 Million | 22.4 Million | -102.94 Million | -71.61 Million | 574.34 Million |
| Free Cash Flow | -235 Million | 606.92 Million | 413.42 Million | 310.38 Million | 446.3 Million | 372 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 55.07 Million | 47.46 Million | 64.32 Million | -76.07 Million | 254.21 Million | 101.5 Million |
| Depreciation & Amortization | - | 44.42 Million | 44.42 Million | 143.72 Million | 147.24 Million | -71.07 Million |
| Deferred income taxes | - | - | - | - | -24.75 Million | - |
| Stock-based compensation | - | 2.36 Million | - | 1.57 Million | 1.57 Million | - |
| Change in working capital | - | 45.23 Million | - | 244.52 Million | -308 Million | 86.99 Million |
| Other non-cash items | 148.5 Million | 148.38 Million | -229.64 Million | -135.05 Million | 47.7 Million | -29.82 Million |
| Investing Cash Flow | -195.49 Million | -125.65 Million | -355.58 Million | -81.99 Million | -602.8 Million | -273.42 Million |
| Investments in PPE | -124.15 Million | -136.6 Million | -112.28 Million | -156.22 Million | -511.94 Million | -121.83 Million |
| Acquisitions | 9.11 Million | -865.31 Thousand | 6.75 Million | -35.01 Million | -202.18 Million | -168.41 Million |
| Investment purchases | -363.79 Million | -181.21 Million | -298.97 Million | -84.69 Million | -290.77 Million | -57.34 Million |
| Sales/Maturities of investments | 283.31 Million | 200.99 Million | 48.63 Million | 202.88 Million | 430.73 Million | 74.35 Million |
| Other Investing Activities | 23.52 Thousand | -8 Million | -243.3 Million | -9.88 Million | -29.71 Million | -191.69 Thousand |
| Financing Cash Flow | -101.29 Million | 154.95 Million | 577.12 Million | -156.9 Million | -675.86 Thousand | 46.43 Million |
| Debt repayment | -76.61 Million | -6.56 Million | -192.99 Million | -92.22 Million | -105.16 Million | -109.7 Million |
| Dividends payments | -22.7 Million | -103.07 Million | -6.34 Million | -123.68 Million | -123.68 Million | -173.95 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.97 Million | 291.55 Million | 390.47 Million | -8.91 Million | 152.48 Million | 330.09 Million |
| Accounts receivables | - | -147.2 Million | - | 174.74 Million | 174.74 Million | -18.74 Million |
| Accounts payables | - | - | - | - | -524.11 Million | -38.05 Million |
| Inventory | - | 170.81 Million | - | 66.11 Million | 66.11 Million | 105.73 Million |
| Other working capital | - | 21.61 Million | - | 3.66 Million | 3.66 Million | 38.05 Million |
| Cash at beginning of period | 847.67 Million | 668.93 Million | 609.98 Million | 666.69 Million | 926.85 Million | 803.29 Million |
| Cash at end of period | 754.12 Million | 847.67 Million | 668.93 Million | 607.73 Million | 607.73 Million | 666.69 Million |
| Capital Expenditure | -124.15 Million | -136.6 Million | -112.28 Million | -156.22 Million | -511.94 Million | -121.83 Million |
| Effect of forex changes on cash | 500.01 Thousand | 4.15 Million | 2.73 Million | 2.81 Million | 7.41 Million | 2.8 Million |
| Net cash flow / Change in cash | -93.55 Million | 178.74 Million | 58.95 Million | -58.95 Million | -319.11 Million | -136.59 Million |
| Free Cash Flow | 79.43 Million | 14.81 Million | -277.6 Million | 20.9 Million | -235 Million | -34.24 Million |
002287
8447
WISA
000705
0519
267250